Presentations

The Biotech Specialised In Diseases of Aging
Stanislas Veillet...
21 May, 2018
Senhwa Biosciences, Inc
Benny Hu, Tai-Sen...
19 May, 2018
Real World Evidence: Sanofi's Strategy
Ameet Nathwani MD...
17 May, 2018
Developing First-In-Class Cardiovascular Drugs
Lionel Segard, Je...
09 May, 2018
Phase 1/2, Randomized, Placebo Controlled and Open Label Extension Studies of Givosiran, an Investigational RNA Interference (RNAi) Therapeutic, in Patients with Acute Intermittent Porphyria
Eliane Sardh MD P...
06 May, 2018
Precision Nanomedicine for People An (almost) invisible revolution
Johanna K Scheper...
03 May, 2018
Sea Food Security, Thanks to Algae
Martin C. Th. Sch...
25 April, 2018
Trends in Neuro Device Investing
Bill Sideris, Chr...
20 April, 2018
weSRCH App on Apple
Ticagrelor with Aspirin on Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (PRINCE) Trial
Yilong Wang MD Ph...
19 April, 2018
Heat Biologics
Heat Biologics, I...
09 April, 2018
Novartis Pharmaceuticals: Driving Growth
Paul Hudson
06 April, 2018
Global integrated biotech developing marine-inspired and novel MoA oncology drugs
PharmaMar
05 April, 2018
Advancing Breakthrough Products  for Blood Clots and Blood Cancers to the Market
Portola Pharmaceu...
04 April, 2018
Regulation and Innovation in Japan
Takao Yamori PhD
02 April, 2018
Fennec Pharma

Fennec Pharma

During the course of this presentation we will mak

Khalis Islam PhD,...
29 March, 2018
Regulation of Cell and Gene Therapy Products in Taiwan
Wan-Yu Chen
27 March, 2018
Pharma 2020: The vision
Simon Friend, Ste...
21 March, 2018
Novel Checkpoints in Immuno-Oncology
Markus Metzger Ph...
19 March, 2018
Oncolytic Immunotherapeutics Leadership
SillaJen Inc
18 March, 2018
Basket and Umbrella Trial Designs in Oncology
Eric Polley
17 March, 2018